Population Immunogenetics: HLA & KIR Genotyping, Diversity and Association Analysis
Overview
Population immunogenetics asks how highly polymorphic immune loci vary across cohorts and how that variation relates to ancestry, immune phenotypes, exposures, or research outcomes. HLA and KIR require specialized treatment: HLA genes combine extensive allelic diversity with strong, population-specific linkage disequilibrium, while the KIR region varies in gene content, copy number, haplotype structure, and allele sequence.
CD Genomics supports research cohorts with HLA and KIR genotyping, harmonized nomenclature, allele and genotype frequencies, haplotype analysis, Hardy-Weinberg evaluation, linkage disequilibrium, population differentiation, cross-population comparison, and association-ready outputs. The workflow supports population discovery, biomarker research, translational studies, and preclinical pharmaceutical programs.
- Move beyond sample-by-sample typing: one cohort framework connects genotype QC with population frequencies and statistical comparisons.
- Respect locus complexity: resolution, ambiguity, gene content, copy number, and reference-version decisions are documented instead of compressed into a generic SNP table.
- Analyze HLA and KIR jointly: receptor, ligand, and haplotype combinations can be summarized when study design and typing resolution support them.
Figure 1: Population immunogenetics integrates cohort-level HLA and KIR variation rather than treating each typing result in isolation.
HLA and KIR Analysis Scope
| Layer | Representative Outputs | Research Value |
| HLA typing | Agreed class I/class II loci, allele resolution, ambiguity and QC fields | Creates comparable HLA calls for frequency, haplotype, diversity, and association studies. |
| KIR typing | Gene presence/absence, gene-content profile, and allele or copy-number scope when technically supported | Captures structural and allelic variation that ordinary SNP-only analysis can miss. |
| Population summaries | Allele, genotype, phenotype, gene-content, and haplotype frequencies | Describes immune-genetic composition within and among defined cohorts. |
| Population tests | Hardy-Weinberg evaluation, LD, diversity, differentiation, and ancestry-aware comparisons | Reveals structure and potential confounding before association interpretation. |
| Joint analysis | HLA ligand groups, KIR/HLA combinations, and association-ready matrices | Supports research questions that depend on receptor-ligand context rather than one locus alone. |
Which Approach Fits Your Study?
| Study Objective | Recommended Path | Key Consideration |
| Population reference or ancestry comparison | Cohort genotyping followed by harmonized population analysis | Match resolution and nomenclature across cohorts before frequency or diversity comparisons. |
| Case-control or phenotype association | Typing plus association-ready matrices with covariates | Define phenotypes, covariates, relatedness, and multiple-testing control before testing. |
| Existing WGS or WES data in hand | Inference from existing sequencing data where suitable | Read length, coverage, locus representation, and required resolution determine feasibility. |
| No sequence data; high-resolution calls needed | Direct targeted typing within the agreed locus scope | Class I, class II, and KIR scope are reviewed before the final design. |
| Receptor-ligand or haplotype questions | Joint HLA-KIR feature analysis | Requires loci, sample size, and typing resolution that support combination-level tests. |
| Single-sample typing without a cohort question | Outside this population service | Population analysis requires defined groups, metadata, and harmonized calls. |
Cohort and Study Design
Typing resolution must match the biological question and the evidence available from the selected assay or existing data. Population labels, ancestry information, recruitment site, relatedness, phenotype definitions, treatment or exposure variables, and laboratory batches are reviewed before analysis. This prevents differences in sampling or resolution from being mistaken for immune-genetic effects.
- Reference population studies: estimate HLA or KIR diversity and frequencies within an underrepresented population.
- Case-control cohorts: test allele, genotype, haplotype, gene-content, or receptor-ligand associations while addressing covariates and population structure.
- Multi-population comparisons: harmonize resolution and nomenclature before comparing frequency, diversity, LD, or differentiation.
- Longitudinal or exposure studies: organize immune-genetic features with time-stable genotypes and changing phenotypes or exposures.
- Pharmaceutical and preclinical research: provide cohort-level immunogenetic evidence for biomarker discovery, safety research, response stratification, target evaluation, and population-aware study design.
Related cohort context can be developed through Population Pharmacogenomic Analysis, Pharmacogenomics and PRS, Genome-wide Association Analysis, and Population Structure Analysis.
Figure 2: Cohort definition, typing resolution, and statistical comparisons are aligned before population analysis.
Population Immunogenetics Project Specifications
| Parameter | Typical Scope | Review Point | Why It Matters |
| Loci and resolution | Agreed class I/class II HLA loci and KIR gene-content or allele scope | Locus list, allele resolution, and assay or data-source capability | Resolution must match the biological question or frequencies become incomparable. |
| Input data | Genomic DNA, compatible sequencing data, or genotype files | Data source, locus coverage, read length, and coverage depth | Determines whether direct typing, inference, or reanalysis is appropriate. |
| Nomenclature and references | Versioned IPD-IMGT/HLA and KIR reference databases | Database version, nomenclature, and allele definition | Versioned references make cohort comparisons reproducible. |
| Population definition | Documented cohorts, ancestry, recruitment site, and sampling groups | Relatedness, batch structure, group balance, and missing metadata | Prevents sampling differences from being mistaken for immune-genetic effects. |
| QC and ambiguity handling | Call completeness, ambiguity fields, gene-content uncertainty, and copy-number limits | Missing loci, ambiguity rules, and exclusion criteria | Silently compressed ambiguity can create apparent frequency differences. |
| Analysis modules | Frequencies, HWE, LD, haplotypes, diversity, differentiation, joint features, association | Statistics matched to design, covariates, and multiple-testing control | Scoped tests keep population and association conclusions defensible. |
| Deliverables | Genotype or gene-content tables, QC, frequency tables, association matrices, figures, report | Method versions, filters, denominators, and interpretation limits | Traceable outputs let downstream users audit every frequency or association. |
Population Immunogenetics Workflow
1. Question and cohort review
We define loci, populations, phenotypes, covariates, sample relationships, typing resolution, and intended comparisons.
2. Input and method assessment
Genomic DNA, compatible sequencing data, or genotype files may be considered. Data source and locus coverage determine whether direct typing, inference, or reanalysis is appropriate.
3. HLA and KIR typing
Calls are generated for the agreed scope with reference database and nomenclature versions recorded. Ambiguities, missing loci, gene-content uncertainty, and copy-number limits are retained in QC outputs.
4. Cohort harmonization
Alleles are normalized to a common nomenclature and resolution. Duplicate samples, call completeness, group balance, relatedness information, and batch patterns are reviewed.
5. Population and association analysis
Frequencies, HWE, LD, haplotypes, diversity, differentiation, joint HLA-KIR features, or association tests are run according to the confirmed design.
6. Interpretation and delivery
Results are delivered with method versions, filters, denominators, ambiguity handling, population definitions, visualizations, and stated analytical boundaries.
Figure 3: Population immunogenetics proceeds from cohort definition and typing through harmonization to population and association statistics.
Population-Level Analyses
Frequency, HWE, and Linkage Disequilibrium
Allele and genotype frequencies are reported with explicit denominators and missing-call handling. HWE results are interpreted alongside genotyping quality, population mixture, relatedness, selection, and sample size; a deviation is not automatically a laboratory error or biological discovery. LD and haplotype estimates are calculated only at compatible resolution and with uncertainty considered.
Diversity and Cross-Population Comparison
Heterozygosity, allele richness, frequency distance, differentiation, PCA or related summaries can place the focal cohort in a wider population context. Comparisons require matched locus definitions and allele resolution because apparent differences may otherwise reflect nomenclature or data-generation choices.
Joint HLA-KIR Features
KIR gene content or alleles may be grouped with recognized HLA ligand categories and cohort phenotypes. These combinations are analyzed as research variables; their biological interpretation depends on receptor specificity, expression, copy number, ancestry, and the study context.
Association Support
Allele, amino-acid, haplotype, gene-content, or joint-feature matrices can be tested with relevant covariates and multiple-testing control. Population structure and relatedness should be evaluated before interpreting associations, especially in admixed or multi-site cohorts.
Figure 4: Representative analysis views connect typing quality with population frequencies and cohort comparisons.
Deliverables
- HLA and KIR genotype or gene-content tables for the agreed loci and resolution
- Per-sample call completeness, ambiguity, and locus-level QC
- Allele, genotype, phenotype, and haplotype frequency tables
- HWE, LD, diversity, differentiation, and cross-population results as scoped
- Joint HLA-KIR or receptor-ligand feature tables where supported
- Association results with effect estimates, statistical tests, covariates, and multiple-testing fields
- Figures, methods, database versions, and an interpretation report
Best For and Not For
| Best For | Not For |
| Population reference cohorts, immunogenetics consortia, ancestry comparisons, immune-mediated or infectious-disease research cohorts, and pharmaceutical or preclinical biomarker research | Single-sample typing without a cohort question, poorly defined population groups, incompatible typing resolutions, or studies lacking the metadata needed for population comparison |
Case Study: Population-Scale HLA Diversity in the United Arab Emirates
Investigating the genetic makeup of the major histocompatibility complex (MHC) in the United Arab Emirates population through next-generation sequencing
Journal: Scientific Reports
Published: 2024
Marzouka NA, Alnaqbi H, Al-Aamri A, Tay G, Alsafar H. Investigating the genetic makeup of the major histocompatibility complex (MHC) in the United Arab Emirates population through next-generation sequencing. Scientific Reports. 2024;14:3392.
Existing HLA information for the UAE population was limited by cohort size or typing resolution. The study sought to characterize a larger population and compare its HLA landscape with regional and global datasets.
The researchers analyzed 570 unrelated healthy UAE citizens using WGS or WES data. HLA alleles were inferred with HLA-LA and xHLA, a subset was evaluated by targeted high-resolution typing, and population frequencies and relationships were compared with other datasets.
The study identified a broad HLA repertoire and reported a population profile shaped by the UAE's regional and intercontinental history. Cross-population analysis placed the cohort in relation to 99 comparison populations and highlighted both Middle Eastern similarity and distinctive frequency patterns.
Figure 5: Original case-study summary of the cohort, HLA analysis, and cross-population findings reported by Marzouka et al. (2024).
The study illustrates why population-scale HLA analysis requires a harmonized cohort, explicit typing resolution, validation, and appropriate comparison populations. This framework can support ancestry research, biomarker discovery, and population-aware translational study design.
Why CD Genomics for Population Immunogenetics
CD Genomics links complex-locus typing with population analysis so that nomenclature, resolution, ambiguity, and cohort structure remain visible throughout the project.
Question-led locus and resolution planning: the typing scope is matched to frequency, haplotype, diversity, or association objectives.
Versioned immune-genetics references: allele nomenclature and reference database versions are recorded for reproducible cohort comparison.
Cohort-aware QC: missingness, ambiguity, batch, ancestry, and relatedness are evaluated before population conclusions.
Integrated analysis: HLA, KIR, population covariates, and research phenotypes can be delivered in one traceable analysis framework.FAQs
The locus list depends on the research question, input type, assay, and desired resolution. Class I, class II, KIR gene content, and higher-resolution KIR scope are reviewed before the final design.
Potentially. Suitability depends on read length, coverage, alignment, reference representation, locus, and required resolution. Existing data are assessed before inference; direct targeted typing may be preferable for some objectives.
Ambiguities are retained and summarized rather than silently resolved. Population analyses use a harmonized resolution and documented rules so that frequency differences do not arise from inconsistent call compression.
Yes, when the relevant loci, sample size, cohort variables, and typing resolution support the analysis. The feature definitions and multiple-testing strategy are agreed before testing.
Yes. Cohort-level HLA and KIR features can support biomarker discovery, immune-response research, population stratification, safety research, and hypothesis generation for preclinical programs. The analysis scope is matched to the cohort design and available phenotype or exposure data.
Related Population Genomics Services
Connect immunogenetic results with Genome-wide Association Analysis, Linkage Disequilibrium Analysis, Population Structure Analysis, Genetic Diversity Analysis, or Population Pharmacogenomic Analysis.
References
- Barker DJ, Maccari G, Georgiou X, et al. The IPD-IMGT/HLA Database. Nucleic Acids Research. 2023;51(D1):D1053-D1060. View article by DOI.
- Gonzalez-Galarza FF, McCabe A, Melo Dos Santos EJ, et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Research. 2020;48(D1):D783-D788. View article by DOI.
- Luo Y, Kanai M, Choi W, et al. A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response. Nature Genetics. 2021;53:1504-1516. View article by DOI.
- Downing J, D'Orsogna L. High-resolution human KIR genotyping. Immunogenetics. 2022;74:369-379. View article by DOI.
- Norman PJ, Hollenbach JA, Nemat-Gorgani N, et al. Defining KIR and HLA class I genotypes at highest resolution via high-throughput sequencing. American Journal of Human Genetics. 2016;99(2):375-391. View article by DOI.
- Marzouka NA, Alnaqbi H, Al-Aamri A, Tay G, Alsafar H. Investigating the genetic makeup of the major histocompatibility complex (MHC) in the United Arab Emirates population through next-generation sequencing. Scientific Reports. 2024;14:3392. View article by DOI.
Related
Services
Download
